Active Stocks
Thu Mar 28 2024 14:59:25
  1. Tata Steel share price
  2. 156.00 2.06%
  1. HDFC Bank share price
  2. 1,452.00 0.78%
  1. ITC share price
  2. 429.85 0.43%
  1. Power Grid Corporation Of India share price
  2. 277.70 2.45%
  1. State Bank Of India share price
  2. 754.75 2.82%
Business News/ Companies / News/  Glenmark to reduce R&D spending as challenges mount
BackBack

Glenmark to reduce R&D spending as challenges mount

Glenmark will limit R&D spending to 11%-12% of sales for three years as it confronts a challenging business environment in key markets, particularly the US

Glenn Saldanha, chairman and managing director, Glenmark Pharmaceuticals. Photo: Ramesh Pathania/Mint (Ramesh Pathania/Mint)Premium
Glenn Saldanha, chairman and managing director, Glenmark Pharmaceuticals. Photo: Ramesh Pathania/Mint (Ramesh Pathania/Mint)

Mumbai: Glenmark Pharmaceuticals Ltd, among the early movers in India to invest in discovery of novel drugs, will limit spending on research and development (R&D) to 11-12% of sales for three years as it confronts a challenging business environment in key markets, particularly the US.

Glenmark has been raising spending on R&D annually over the last six years, with investment reaching a record Rs1,262.23 crore in FY17, close to 14% of sales (see chart).

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 04 Oct 2017, 12:18 AM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie